Back
Amicus Therapeutics Stock Predictions
Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
27
FOLD
Amicus Therapeutics
Last Price:
$6.23
Seasonality Move:
22.17%
7 Day Trial
ALL ACCESS PASS
$
7
This $60K Foldable Home Is Shaking Up Real Estate
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Amicus Therapeutics Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 25.1% based on the past 17 years of stock performance.
-
Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
-
Is Amicus Therapeutics Stock Undervalued?The current Amicus Therapeutics [FOLD] share price is $6.22. The Score for FOLD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 25.1% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
27
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
-
Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
12.65
52-Week Low:
5.81
Prediction Charts
Market Cap:
1.9B
Price in USD:
6.22
Volume:
2.8M
Beta:
1.01
Technical Analysis
SMA50:
7.24
SMA100:
8.32
SMA200:
9.54
52-Wk Change:
-34.32%
Stock Predictions
-
Is Amicus Therapeutics stock public?Yes, Amicus Therapeutics is a publicly traded company.
-
What is the Amicus Therapeutics stock quote today?The Amicus Therapeutics stock price is 6.22 USD today.
-
How to buy Amicus Therapeutics stock online?You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 6.50 | 6.19 | 6.59 | 6.14 |
| May-7 | 6.24 | 6.09 | 6.26 | 5.93 |
| May-8 | 5.98 | 6.08 | 6.26 | 5.82 |
| May-9 | 6.09 | 5.98 | 6.29 | 5.97 |
| May-12 | 6.17 | 6.21 | 6.31 | 6.09 |
| May-13 | 6.20 | 6.02 | 6.23 | 6.01 |
| May-14 | 6.03 | 5.88 | 6.11 | 5.87 |
| May-15 | 5.90 | 5.95 | 5.96 | 5.81 |
| May-16 | 5.96 | 6.43 | 6.44 | 5.91 |
| May-19 | 6.38 | 6.42 | 6.51 | 6.27 |
| May-20 | 6.50 | 6.59 | 6.65 | 6.39 |
| May-21 | 6.52 | 6.34 | 6.58 | 6.24 |
| May-22 | 6.30 | 6.26 | 6.35 | 6.20 |
| May-23 | 6.15 | 6.22 | 6.27 | 6.12 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.09 per share, and an increase next year of $0.35 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.